Press Release Description

Rise in Genomics & Proteomics across Asia-Pacific to Drive the Bioinformatics Market

According to MarkNtel Advisors, the Asia-Pacific Bioinformatics Market is expecting around 17% CAGR during 2021-26. The surging need for advanced computational tools in biological research, various firms providing outsourcing services for bioinformatics, and the burgeoning requirements for integrated bioinformatics in genomic & clinical diagnostics are the prime aspects driving the bioinformatics market in Asia-Pacific.

Moreover, massive funding by both government & private sector organizations across Asia-Pacific in the bioinformatics field is also a prominent aspect fueling the growth of the bioinformatics market. It has resulted in rapid data & technological advancements in bioinformatics services.

Nevertheless, the growing proteomics & genomics and various research activities on drug discovery are other notable aspects expected to create significant growth opportunities for the Bioinformatics Market in Asia-Pacific during 2021-26, further states the research report, "Asia-Pacific Bioinformatics Market Analysis, 2021."

Sequencing Platforms to Acquire the Major Share in the Bioinformatics Market through 2026

The declining prices of sequencing, coupled with various technological advancements, owing to substantial investments by governments & private sectors of different countries across Asia-Pacific in NSG (Next-Generation Sequencing) projects are driving the market for sequencing platforms required for thoroughly analyzing have surged the need for massive data generated through sequencing.

Due to reduced prices of sequencing services, most end-users, including forensic laboratories, pharmaceutical & biotechnology industries, academic & research centers, etc., prefer sequencing platforms to evaluate the massive sequencing data.

Moreover, the mounting number of genome mapping programs is another crucial aspect indicating the surging demand for sequencing platforms across Asia-Pacific in the coming years, which, in turn, would further boost the bioinformatics market.

With Massive Government Funding in Bioinformatics, India to Contribute Significantly to the Market Growth

India has been witnessing rapid growth in the bioinformatics industry. The surging requirements for bioinformatics in drug identification & development, coupled with numerous mergers between the leading biotechnology & IT firms, are driving the market across the country. Moreover, immense government support through favorable incentives and significant investments in R&D activities associated with gene sequencing to early diagnose cancer is another prominent factor projecting remunerative opportunities for the bioinformatics market in India over the forecast years, reveals MarkNtel Advisors in their research report, "Asia-Pacific Bioinformatics Market Analysis, 2021."

Competitive Landscape:

The leading players in the Asia-Pacific Bioinformatics Market include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Perkinelmer, Inc., Qiagen Bioinformatics, Agilent Technologies, Dnastar, Waters Corporation, Sophia Genetics, Partek, Biomax Informatics AG, Wuxi Nextcode, Beijing Genomics Institute (BGI).

Key Questions Answered in the Research Report

  1. What are the current & future trends in the Asia-Pacific Bioinformatics Market?
  2. How has the industry been evolving in terms of geography & service adoption?
  3. How has the competition been shaping across Asia-Pacific, followed by their comparative factorial indexing?
  4. What are the key growth drivers & challenges for the Asia-Pacific Bioinformatics Market?
  5. What are the customer orientation, purchase behavior, & expectations from bioinformatics firms across Asia-Pacific?

Market Segmentation:

  1. By-Products & Services (Platforms (Sequence Analysis, Sequence Alignment, Sequence Manipulation, Structural & Functional Analysis), Knowledge Management Tools (Generalized, Specialized), Services (Data Analysis, Database Management))
  2. By Application (Genomics, Metabolomics, Chemoinformatics & Drug Design, Transcriptomics, Proteomics, Others (Molecular Medicine, Preventive Medicine, etc.))
  3. By Type of Sector (Animal Biotechnology, Environmental Biotechnology (Waste Clean-up/ Bioremediation, Alternative Energy Sources), Agriculture Biotechnology (Nutritional Quality Improvement, Biodiversity Informatics, Improvement of Plant Resistance, Pest Resistance, Crop Yield Improvement), Forensic Biotechnology, Medical Biotechnology (Reproductive Biotechnology, Gene Therapy, Molecular Medicine, Clinical Diagnostics, Drug Development), Academics)
  4. By Countries (China, Japan, South Korea, Australia, India, Taiwan, South East Asia)
  5. By Competitors (Thermo Fisher Scientific, Eurofins Scientific, Illumina, Perkinelmer, Inc., Qiagen Bioinformatics, Agilent Technologies, Dnastar, Waters Corporation, Sophia Genetics, Partek, Biomax Informatics AG, Wuxi Nextcode, Beijing Genomics Institute (BGI))